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OBJECTIVE: Esophageal squamous cell carcinoma is one of the most common esophageal diseases in the
developing world, but the relationship between esophageal squamous cell carcinoma and Helicobacter pylori
infection remains a neglected topic. The primary objective of this study was to determine the association
between Helicobacter pylori infection and esophageal squamous cell carcinoma. A second purpose was to
determine the incidence and factors associated with Helicobacter pylori infection following esophagectomy.
METHOD: The microorganism was identified by testing the gastric biopsy materials from 95 esophageal
squamous cell carcinoma patients (66 females; 39 were esophagectomized) for urease activity in a medium
containing urea and a power of hydrogen detection reagent and comparing the results with those from a
healthy population. Differences in patient characteristics were assessed with chi-square tests and t-tests for
categorical and continuous factors, respectively.
RESULTS: The patients with esophageal squamous cell carcinoma had a significantly lower prevalence of
Helicobacter pylori compared with the healthy population (po0.001). The naive and esophagectomized
patients, in contrast, showed no significant differences in Helicobacter pylori infection (p40.005). Patients with
esophageal squamous cell carcinoma showed a significant association between leukocytosis and hypoglobu-
linemia and the presence of Helicobacter pylori infection (p=0.023 and p=0.045, respectively).
CONCLUSION: These results suggest that Helicobacter pylori is not an etiological factor in patients with
esophageal squamous cell carcinoma. We found a statistically significant negative correlation between esoph-
ageal squamous cell cancer and Helicobacter pylori infection. These findings may guide new strategies for
esophageal squamous cell carcinoma therapy.
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’ INTRODUCTION
Esophageal squamous cell carcinoma (ESCC), one of the most
aggressive digestive system tumors, is associated with numer-
ous factors, including advanced age, achalasia, Plummer-Vinson
syndrome, low socioeconomic status, high-starch diets lacking
in fruits and vegetables, alcohol abuse, tobacco use, previous
head and neck squamous cell carcinoma, and radiation ther-
apy (1). It is also an important cause of mortality in the Asian
esophageal cancer belt and in the eastern part of Turkey (2).
Helicobacter pylori (HP), a gram-negative bacterium found
on the gastric mucosa, was first isolated 30 years ago (3).
Infection with HP is one cause of duodenal or gastric ulcers
(reported to develop in 1 to 10% of infected patients), gastric
cancer (in 0.1 to 3%), and gastric mucosa-associated lym-
phoid-tissue (MALT) lymphoma (in o0.01%) (4). Recent
studies have demonstrated a high frequency of HP infection
in gastric cancer patients, suggesting that presence of HP may
function as a driver of the events contributing to oncogen-
esis in gastric adenocarcinomas (5,6). Furthermore, an inverse
association has been established between Cag A-positive HP
infection and the risk of esophageal adenocarcinoma (7). HP
infection plays crucial roles in gastric carcinogenesis; however,
the impact of HP on ESCC is not well understood.
The available data, derived from studies using serologic
tests, are conflicting with respect to any association between
HP and ESCC (8-10). The aim of the present study was to
examine the potential correlation between ESCC and HP
infection and to compare the presence of HP in naive ESCC
patients and their esophagectomized counterparts.
’ PATIENTS AND METHODS
This retrospective trial was conducted at a university
medical center in a large metropolitan area near the Iranian
border of Turkey, where both ESCC and HP infection areDOI: 10.6061/clinics/2017(03)04
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endemic. In total, 95 ESCC patients (65 women, aged 32-
92 years) were evaluated in our clinic from July 2012 to
July 2015. All the patients were diagnosed with ESCC based
on established endoscopic and histopathological criteria. Of
these, 39 had undergone a subtotal esophagectomy. In this
esophagectomy group, esophageal reconstruction was per-
formed through a subcutaneous route in 10 patients, through
a retrosternal route in 25, and through a posterior mediast-
inal route in 4. The reconstructed esophagus was a wide
gastric tube, as described by Holscher (11).
Postoperatively, the patients typically underwent upper
gastrointestinal endoscopy 6 weeks after surgery to deter-
mine the presence or absence of HP infection.
Gastric biopsy samples were tested for urease activity
using a commercial Hp-fast test kit (GI Supplys, Camp Hill,
PA, USA) consisting of a urea-containing medium and a
power of hydrogen (pH) detection reagent.
The control group comprised 151 dyspeptic subjects (100
women and 51 men, aged 30–85 years). Controls were also
required to be medical-treatment free for at least 6 months
from the time of study entry. Antrum biopsies with normal
endoscopic evaluations were examined for HP using the
same method. The prognostic values of the presence of HP
and other clinicopathologic factors were also evaluated.
Statistical analysis
The two groups were compared using the Mann-Whitney
U-test. The differences were considered statistically signifi-
cant at po0.005.
’ RESULTS
The mean age was 52.96±11.81 years in the control group
(100 women), 59.53±13.93 years in the naive ESCC group
(36 females), and 55.95±11.53 years in esophagectomized
group (28 females). Nearly two-thirds of the ESCC patients
were female. Descriptive statistics and comparison results
according to the presence of HP are shown in Table 1.
HP infection was observed in 39 (68.4%) of the 57 naive
ESCC patients, 27 (69.2%) of the 39 esophagectomized
patients, and 128 (85%) of the 151 dyspeptic control patients
(Figure 2). We found a significantly lower rate of HP in
patients with ESCC compared with the dyspeptic subjects
(po0.0001), whereas no statistically significant difference was
detected between the naive ESCC patients and their esopha-
gectomized counterparts (p40.005). We also found no gender
differences between the groups (p40.0005).
Significantly higher levels of leukocytes and serum glob-
ulin were also found in the ESCC patients diagnosed with
HP compared with those without HP infection (p=0.023 for
leukocytes and p=0.045 for serum globulin).
’ DISCUSSION
Our study revealed a strong association between HP infec-
tion and a reduced risk of ESCC. In the Turkish adult popula-
tion, the prevalence of HP infection is higher than reported in
Western countries. A previous investigation of 4622 Turkish
subjects indicated an HP infection prevalence of 82.5% (12).
The prevalence of HP infection in the present study was
Table 1 - Descriptive statistics and comparison results according to Helicobacter pylori status.
HP1 n Mean Std. Dev Min. Max. p
Age (years) + 65 57.02 11.514 32 92 0.239
- 30 60.43 15.939 23 87
Total 95 58.09 13.084 23 92
Hemoglobin (gr/dL) + 63 12.50 2.025 8 17 0.371
- 30 12.11 1.876 9 17
Total 93 12.38 1.976 8 17
Hematocrit + 63 37.20 5.616 24 49 0.427
- 30 36.21 5.502 28 49
Total 93 36.88 5.569 24 49
Leukocytes (/mm3) + 63 7.598 3.8817 1.8 25.0 0.023
- 30 5.803 2.4689 2.0 11.0
Total 93 7.019 3.5760 1.8 25.0
Platelets (/mm3) + 63 270.000 123.839 67.000 702.000 0.150
- 30 616.687 324.542 79.000 178.000
Total 93 443.343 184.309 67.000 178.000
ALT2 (U/L) + 63 18.94 17.766 6 142 0.284
- 30 15.27 8.026 6 39
Total 93 17.75 15.362 6 142
AST3 (U/L) + 62 33.02 48.837 2 341 0.089
- 30 17.57 6.976 9 38
Total 92 27.98 40.833 2 341
Albumin (g/dL) + 58 3.71 0.734 2 5 0.882
- 25 3.69 0.667 2 5
Total 83 3.71 0.711 2 5
Globulin (g/dL) + 47 3.07 0.533 2 4 0.045
- 19 2.73 0.772 1 4
Total 66 2.97 0.625 1 4
Calcium (mg/dL) + 57 8.92 1.362 1 13 0.370
- 27 9.17 0.639 8 11
Total 84 9.00 1.181 1 13
Std. Dev: Standard deviation
1Helicobacter pylori,
2 Alanine transaminase,
3Aspartate transaminase
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similar (85%). Squamous cell carcinomas are usually detected
in the proximal two-thirds of the esophagus. They predomi-
nantly affect elderly people and usually present as dysphagia,
odynophagia, and unintentional weight loss (13). Worldwide,
esophageal cancer ranks fifth in mortality among all malig-
nancies, and ESCC remains the most common type.
In Asia, upper gastrointestinal cancers constitute a major
group of malignancies with high rates of morbidity and
mortality. The esophageal cancer belt, originating in the Far
East and extending through middle Asia and the Near East,
encompasses many countries, including northern China,
northern Iran and the eastern part of Turkey (14). The pre-
dominant histopathological type of esophageal cancer is
the squamous cell type in the endemic Asian regions, with
incidence rates that may vary 200-fold among different
populations within the same defined region due to cultural
practices. More than 80% of ESCC patients in the rural areas
of Asia also present at advanced stages that are not amenable
to curative therapies; hence the need for novel preventive
strategies is urgent (15).
The Van region of eastern Turkey is located in the western
end of the esophageal cancer belt. Esophageal and gastric
cancers are the most prevalent malignancies in both females
and males in eastern part of Turkey (16). The probable culprit
factors for ESCC in this region are low educational and
socioeconomic status; the consumption of smoked, salted,
hot, fatty foods; overconsumption of hot tea; cigarette smok-
ing; poor intake of fresh fruits and vegetables, and poor
hygienic conditions (17). Previous studies have shown that
the eastern part of Turkey has one of the highest rates of
both ESCC and HP infection. An HP infection rate of 36%
was reported for gastric biopsy specimens in patients with
gastric carcinoma from the Van region (18).
Various environmental factors, including cigarette smok-
ing and excessive alcohol intake, can be associated with an
increased risk of developing ESCC (19). HP is considered one
of the most important human carcinogens for the upper
gastrointestinal tract and the stomach (20). At present, a few
reports have indicated a possible relationship between HP
and ESCC, but most of these were performed using non-
endoscopic (serologic) techniques (7). A recent Chinese study
reported an HP seropositivity of 35.3% in ESCC patients,
which was lower than that of the control groups (40% and
59%) (21). A recent meta-analysis also found an association
between CagA-negative HP strains and a marginally signif-
icant increased risk of ESCC (7). In contrast, a prospective
and serological study from China showed no association
between HP and ESCC (22). Another recent meta-analysis
from China showed an association between HP infection
and a decreased risk of ESCC in Eastern populations and
a decreased risk of esophageal adenocarcinoma (EAC) in
the overall population (23).
The current study revealed no association between HP
infection and ESCC among people living in the eastern part
of Turkey. The low prevalence of HP in these ESCC patients
was similar to that reported in the Chinese meta-analyses.
We also found a predominance of ESCC in female patients,
in agreement with a previous Turkish study (17). This phe-
nomenon has been linked to the use of the traditional large
ovens (tandirs) that use smoke to cook meals (Figure 1). The
mechanisms by which these ovens induce esophageal carci-
nogenesis remain undefined, but previous work suggests
that smoke may play role similar to that of cigarette smoking
(17). We conclude that an effective follow-up strategy for
HP-negative female Asian adults will be necessary if ESCC
screening is to yield public health benefits. The higher levels
of leucocytes and serum globulin among ESCC patients with
HP may also reflect an emerging phenomenon that requires
additional investigation to determine the underlying causa-
tive factors.
The H. pylori-fast test (Hp-fast test) is based on the
detection of HP urease activity and has a high sensitivity
(85%) and specificity (495%) for detecting HP infection.
As this test is considered cost-effective and suitable for
endoscopy units (24), we used the Hp-fast test to establish
HP infection.
The current data are limited regarding any changes in the
prevalence of HP in patients who have undergone esopha-
gectomy. We therefore performed gastroduodenoscopy with
pathological examination of the biopsy specimens obtained
from the gastric conduit. We observed that the rate of HP
infection was lower in esophagectomized ESCC patients
than in the control subjects (19% and 78%, respectively;
po0.001). The rate of HP infection was similar, however,
between the naive ESCC patients and the esophagectomized
patients (p40.005). A Japanese study reported that the HP
Figure 1 - Traditional large oven (Tandir).
Figure 2 - Rate of HP according to groups.
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infection status changed from preoperatively positive to
postoperatively negative and that this changing pattern
was linked to the eradication of HP via the perioperative
administration of antibiotics (25). Conversely, a report from
China showed a low incidence of HP infection in the gastric
conduit in patients who underwent esophagectomy, pylor-
oplasty, and reconstruction. The authors of that study con-
cluded that this phenomenon was mostly due to the chronic
reflux of bile after pyloroplasty (26).
Our findings were in concordance with previous reports
on HP status and gastric tube cancer patients. In our Turkish
population, HP infection was not associated with ESCC and
had a similar pattern to that reported for Asian populations.
HP infection may not contribute to the development of ESCC
in patients who reside in rural areas of Asia, especially not in
females. Furthermore, esophageal damage could be dimin-
ished by the prior presence of HP in areas with a high risk
of ESCC. HP treatment has been associated with impro-
ved thrombocyte levels. An increase in platelet counts was
observed in only 6.7% of treated patients. In the current
study, we found no relationship between HP status and
thrombocyte levels (27,28).
Finally, further studies are needed to address the impact
of HP infection on ESCC and its natural history.
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